title: Three cases of severe hepatic impairment caused by erlotinib.
authors.forename: Yi-Sheng
authors.initials: YS
authors.lastname: Huang
authors.forename: She-Juan
authors.initials: SJ
authors.lastname: An
authors.forename: Zhi-Hong
authors.initials: ZH
authors.lastname: Chen
authors.forename: Yi-Long
authors.initials: YL
authors.lastname: Wu
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001706:Biopsy; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride